Navigation Links
Masimo Rad-87(R) Pulse CO-Oximeter(TM) Garners Silver 2009 Medical Design Excellence Award

IRVINE, Calif., July 14 /PRNewswire-FirstCall/ -- Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, has received the 2009 Silver Medical Design Excellence Award in the general hospital devices and therapeutic products category for the Masimo Rad-87 Pulse CO-Oximeter. The award recognizes Rad-87's excellence in medical technology engineering and design as an intuitive bedside patient monitor that helps improve clinical efficiency and keep patients safe when a clinician can't be at the bedside.

The Masimo Rad-87 features the breakthrough noninvasive blood constituent monitoring capabilities of Masimo Rainbow SET((R)) Pulse CO-Oximetry for continuous monitoring of hemoglobin, carbon monoxide, methemoglobin, PVI (fluid responsiveness), perfusion index, and measure through motion pulse oximetry with upgradability to acoustic respiration rate monitoring. Its built-in 802.11a/b/g radio allows wireless communication with the Masimo Patient SafetyNet(TM) remote monitoring and clinician notification system to provide patients with an enhanced level of safety on general care floors. Designed for ease-of-use, the Rad-87 allows the features clinicians need most often to be accessed with a single touch. And, as the first Masimo Rainbow SET device with a bright white LED-based display, its high contrast visual display allows measurements to be clearly seen from across the room, while an innovative new device profile feature lets clinical settings be customized and color-coded for a particular care area.

Masimo Founder and CEO, Joe E. Kiani, stated, "It is an honor to receive our third Medical Design Excellence Award for product design and engineering innovations that improve healthcare delivery and advance medical practices. We received the Gold Medical Design Excellence Award in 2006 for the Masimo Rad-57 Pulse CO-Oximeter and in 2001 for the Masimo Radical Signal Extraction pulse oximeter."

The Medical Design Excellence Awards (MDEA) competition is the only awards program that exclusively recognizes advances in the design of medical products and the achievements of medical device manufacturers responsible for the groundbreaking innovations that are changing the face of healthcare. 2009 MDEA winners were announced and honored at the June 10th ceremony during the Medical Design & Manufacturing (MD&M) East Conference and Exposition in New York. For more information about the Medical Design Excellence Awards--including details about the winning products--visit

About Masimo

Masimo (NASDAQ: MASI) develops innovative monitoring technologies that significantly improve patient care--helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through-Motion-and-Low-Perfusion pulse oximetry, known as Masimo SET, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 independent and objective studies demonstrate Masimo SET provides the most reliable SpO2 and pulse rate measurements even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced Masimo Rainbow SET Pulse CO-Oximetry, a breakthrough noninvasive blood constituent monitoring platform that can measure many blood constituents that previously required invasive procedures. Masimo Rainbow SET continuously and noninvasively measures total hemoglobin (SpHb(TM)), oxygen content (SpOC(TM)), carboxyhemoglobin (SpCO((R))), methemoglobin (SpMet((R))), and PVI(TM), in addition to oxyhemoglobin (SpO2), pulse rate (PR), and perfusion index (PI), allowing early detection and treatment of potentially life-threatening conditions. Founded in 1989, Masimo has the mission of "Improving Patient Outcomes and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications." Additional information about Masimo and its products may be found at

Forward Looking Statements

This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: risks related to our belief that the features, function and design of the Masimo Rad-87 Pulse CO-Oximeter will enable clinicians to detect and treat life-threatening conditions earlier, improve patient outcomes, increase clinical efficiency gains, and reduce the cost of care for patients, risks related to our belief that Masimo Rainbow SET Pulse CO-Oximetry technology will provide a sufficient level of sensitivity and specificity to facilitate the noninvasive, continuous measurement of multiple blood constituents, fluid assessment and physiological parameters, risks related to our assumption that the combination of Masimo Rad-87 and Masimo Patient SafetyNet will help clinicians keep patients safe on general care floors, as well as other factors discussed in the "Risk Factors" section of our Quarterly Report on Form 10-Q for the fiscal quarter year ended April 4, 2009, filed with the Securities and Exchange Commission ("SEC") on May 6, 2009, which may be obtained for free at the SEC's website at Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarify these forward-looking statements or the "Risk Factors" contained in our Quarterly Report on Form 10-Q for the fiscal quarter year ended April 4, 2009, filed with the Securities and Exchange Commission ("SEC") on May 6, 2009, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.

    Dana Banks
    Masimo Corporation

Masimo, SET, Signal Extraction Technology, Improving Outcomes and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications, Rainbow, SpHb, SpOC, SpCO, SpMet, PVI, Radical-7, Rad-87, Rad-57, Rad-9, Rad-8, Rad-5, Pulse CO-Oximetry and Pulse CO-Oximeter are trademarks or registered trademarks of Masimo Corporation.

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Masimo Debuts New Rad-8(R) Pulse Oximeter to Largest Gathering of Sleep Specialists From Around the World at SLEEP 2009
2. Leading University Hospital Completes System-Wide Conversion to Masimo SET(R) Pulse Oximetry
3. FEMA Adds Masimo Rad-57(R) Pulse CO-Oximeter(TM) to Required Medical Equipment List
4. Capgemini Releases New Study on Financial Impact of Masimo Noninvasive and Continuous Hemoglobin (SpHb(TM))
5. New Clinical Study Finds Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) Accurate in the Noninvasive Monitoring of Fluid Status During Surgery
6. Masimo to Present at the Cowen and Company 29th Annual Healthcare Conference
7. Masimo Reports Fourth Quarter and Full Year 2008 Financial Results
8. Three Healthcare GPOs to Offer Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) to Their Members
9. Masimo to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference
10. Masimo to Report Fourth Quarter and Fiscal Year 2008 Financial Results on March 3, 2009
11. Masimo Files Patent Infringement Suit Against Philips
Post Your Comments:
(Date:11/25/2015)... ... 2015 , ... The holiday season is jam-packed with family ... of attendees is of the utmost importance. Whether you are cooking at home ... recipes a try this holiday season. , Turkey Croquettes ,     Ingredients: ...
(Date:11/25/2015)... ... November 26, 2015 , ... Ministers, senior government and ... Pan African Centres of Excellence, and public R&D institutions, civil societies and other ... of the 5th African Network for Drugs and Diagnostics Innovation, ANDI, Stakeholders Meeting. ...
(Date:11/25/2015)... ... , ... Dental professionals who would like to become more proficient on their ... Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses will be held on December ... of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio are proud to announce ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for the ... of the benefits of Botox® in the treatment of moderate facial wrinkling, few have ... pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism (the ...
(Date:11/25/2015)... PITTSBURGH, PA (PRWEB) , ... November 25, 2015 , ... ... rain,” said an inventor, from Bronx, N.Y. “I thought there had to be a ... She invented the PROTECTOR. , The PROTECTOR enables disabled individuals to safely travel during ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 2015  The total global healthcare industry is expected to ... Latin America has the highest projected growth ... Japan ), is second with growth projected at ... increased healthcare expenditure. In 2013-2014, total government funded healthcare was ... 2008-2009 to 41.2% in 2013-2014. In real terms, out of ...
(Date:11/25/2015)...  The American Academy of Pediatrics (AAP), American ... March of Dimes cheered today,s signature into law ... of 2015 (S.799), which takes much-needed strides ... to drugs, such as opioids, and to improve ... organizations have worked together leading advocacy efforts for ...
(Date:11/25/2015)... , Nov. 25, 2015 AAIPharma ... planned investment of at least $15.8  Million to ... Wilmington, NC . The expansion will ... to meet the growing demands of the pharmaceutical ... site expansion will provide up to 40,000 ...
Breaking Medicine Technology: